138 results
Page 4 of 7
424B5
efdrmnm ec
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
0u4cgs
15 Apr 13
Other Events
12:00am
8-K
EX-99.2
zwouwpc 09xy36zvhjhs
4 Jan 13
Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer
12:00am
8-K
EX-99.1
wasmgzs
24 Oct 12
Other Events
12:00am
8-K
i0wlg3xxquc5q6nghtq
24 Oct 12
Other Events
12:00am
8-K
EX-99.1
6i0vd 40xn
3 May 12
Discovery Labs Reports First Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
xcwpmkhj
29 Mar 12
Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones
12:00am
424B5
v46h63cfjvr
19 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
hfnm1i3hn3wgakxg
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
8xjgav muanjt
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
6w0z8u wa4qwg
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am